Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,108 | 5,641 | 7,169 | 13,382 | 20,405 |
| Receivables | N/A | N/A | 96 | 96 | 227 |
| Other current assets | 30 | 428 | 503 | 537 | 488 |
| TOTAL | $9,864 | $7,113 | $8,335 | $14,820 | $21,656 |
| Non-Current Assets | |||||
| Investments And Advances | 5,350 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 2,984 | 3,121 | 3,259 | 3,397 |
| TOTAL | $5,350 | $2,984 | $3,121 | $3,259 | $3,397 |
| Total Assets | $15,214 | $10,097 | $11,456 | $18,079 | $25,053 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 814 | 1,864 | 3,925 | 2,970 | 1,645 |
| Accrued Expenses | 1,527 | 3,083 | 3,606 | 4,657 | 6,884 |
| TOTAL | $2,341 | $4,947 | $7,531 | $7,627 | $8,529 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,341 | $4,947 | $7,531 | $7,627 | $8,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,445 | 2,411 | 2,176 | 2,176 | 2,175 |
| Retained earnings | -262,723 | -270,289 | -266,108 | -259,154 | -251,938 |
| Other shareholders' equity | -18 | -16 | -19 | -20 | -28 |
| TOTAL | $12,873 | $5,150 | $3,925 | $10,452 | $16,524 |
| Total Liabilities And Equity | $15,214 | $10,097 | $11,456 | $18,079 | $25,053 |